MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Use with caution

Co-amoxiclav 500mg/125mg tablets (Medihealth (Northern) Ltd)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 500mg/125mg tablets suppliers

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd).

Use with caution

Co-amoxiclav 500mg/125mg tablets (Medreich Plc)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 500mg/125mg tablets suppliers

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd).

Use with caution

Co-amoxiclav 500mg/125mg tablets (Milpharm Ltd)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 500mg/125mg tablets suppliers

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd).

Use with caution

Co-amoxiclav 500mg/125mg tablets (Noumed Life Sciences Ltd)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 500mg/125mg tablets suppliers

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd).

Use with caution

Co-amoxiclav 500mg/125mg tablets (Phoenix Healthcare Distribution Ltd)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 500mg/125mg tablets suppliers

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd).

Use with caution

Co-amoxiclav 500mg/125mg tablets (Rivopharm (UK) Ltd)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 500mg/125mg tablets suppliers

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd).

Use with caution

Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 500mg/125mg tablets suppliers

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd).

Use with caution

Co-amoxiclav 500mg/125mg tablets (Sigma Pharmaceuticals Plc)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 500mg/125mg tablets suppliers

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd).

Use with caution

Co-amoxiclav 500mg/125mg tablets (Sun Pharma UK Ltd)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 500mg/125mg tablets suppliers

Stability Notes

Clavulanate powder is hygroscopic. Avoid exposure to excessive humidity. Store in tight containers. Maximum of 7 days in MCA.

Provenance

This compatibility recommendation is derived from Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) and Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd).

No Stability Information

Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)

Explore other Co-amoxiclav formulations Explore other Co-amoxiclav 875mg/125mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

Incompatible

Co-beneldopa 12.5mg/50mg capsules (A A H Pharmaceuticals Ltd)

Explore other Co-beneldopa formulations Explore other Co-beneldopa 12.5mg/50mg capsules suppliers

Stability Notes

Complex dosing regime. Protect from moisture. Unsuitable.

Provenance

This compatibility recommendation is derived from Co-beneldopa 12.5mg/50mg capsules (Teva UK Ltd) and Madopar 50mg/12.5mg capsules (Roche Products Ltd).

Incompatible

Co-beneldopa 12.5mg/50mg capsules (Alliance Healthcare (Distribution) Ltd)

Explore other Co-beneldopa formulations Explore other Co-beneldopa 12.5mg/50mg capsules suppliers

Stability Notes

Complex dosing regime. Protect from moisture. Unsuitable.

Provenance

This compatibility recommendation is derived from Co-beneldopa 12.5mg/50mg capsules (Teva UK Ltd) and Madopar 50mg/12.5mg capsules (Roche Products Ltd).

Incompatible

Co-beneldopa 12.5mg/50mg capsules (Medihealth (Northern) Ltd)

Explore other Co-beneldopa formulations Explore other Co-beneldopa 12.5mg/50mg capsules suppliers

Stability Notes

Complex dosing regime. Protect from moisture. Unsuitable.

Provenance

This compatibility recommendation is derived from Co-beneldopa 12.5mg/50mg capsules (Teva UK Ltd) and Madopar 50mg/12.5mg capsules (Roche Products Ltd).

Incompatible

Co-beneldopa 12.5mg/50mg capsules (Teva UK Ltd)

Explore other Co-beneldopa formulations Explore other Co-beneldopa 12.5mg/50mg capsules suppliers

Stability Notes

Complex dosing regime. Protect from moisture. Unsuitable.

Provenance

This compatibility recommendation is derived from Co-beneldopa 12.5mg/50mg capsules (Teva UK Ltd) and Madopar 50mg/12.5mg capsules (Roche Products Ltd).

Use with caution

Co-careldopa 10mg/100mg tablets (A A H Pharmaceuticals Ltd)

Explore other Co-careldopa formulations Explore other Co-careldopa 10mg/100mg tablets suppliers

Stability Notes

Complex dosing regime. Protect from moisture. Max 7 days in MCA.

Provenance

This compatibility recommendation is derived from Sinemet 10mg/100mg tablets (Organon Pharma (UK) Ltd).

Print this list

Compatible

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.

Use with caution

Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.

Incompatible

Medicines under this category are not suitable for use inside MCAs.

No Stability Information

We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.